Initial Experience with Repetitive Transarterial Chemoembolization (TACE) as a Third Line Treatment of Ovarian Cancer Metastasis to the Liver: Indications, Outcomes and Role in Patient's Management

Citation:
Vogl, T. J., N. N. N. Naguib, T. Lehner, A. Nour-Eldin, K. Eichler, S. Zangos, and Tatjana, "Initial Experience with Repetitive Transarterial Chemoembolization (TACE) as a Third Line Treatment of Ovarian Cancer Metastasis to the Liver: Indications, Outcomes and Role in Patient's Management", Physical Review Letters, 2012.

Abstract:

Objective: To evaluate local tumor control and survival data after transarterial chemoembolization (TACE) with different drug combinations in the palliative third-line treatment of patients with ovarian cancer liver metastases.Methods: Sixty-five patients (mean age: 51.5 year) with unresectable hematogenous hepatic metastases of ovarian cancer who did not respond to systemic chemotherapy were repeatedly treated with TACE in 4-week intervals. The local chemotherapy protocol consisted of Mitomycin (group 1) (n=14; 21.5%),

Notes:

n/a